Other

Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans

West Pharmaceutical Services Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans increased by 33.3% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from $1.90M to $2.00M. Over 3 years (FY 2021 to FY 2025), Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans shows a downward trend with a -3.6% CAGR.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
Metric ID: other_proceeds_from_issuance_of_shares_under_incentive_a_8c89d4

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.10M$1.80M$2.00M$2.00M$1.20M$1.80M$1.70M$1.80M$1.80M$2.00M$1.70M$1.90M$1.60M$1.90M$1.70M$1.80M$1.50M$2.00M
QoQ Change—-14.3%+11.1%+0.0%-40.0%+50.0%-5.6%+5.9%+0.0%+11.1%-15.0%+11.8%-15.8%+18.8%-10.5%+5.9%-16.7%+33.3%
YoY Change———+11.1%-40.0%——-10.0%+50.0%+11.1%+0.0%+5.6%-11.1%-5.0%+0.0%-5.3%-6.3%+5.3%
Range$1.20M – $2.10M
CAGR-1.1%
Avg YoY Growth+0.4%
Median YoY Growth+0.0%

Frequently Asked Questions

What is West Pharmaceutical Services's proceeds from issuance of shares under incentive and share based compensation plans?
West Pharmaceutical Services (WST) reported proceeds from issuance of shares under incentive and share based compensation plans of $2.00M in Q1 2026.
How has West Pharmaceutical Services's proceeds from issuance of shares under incentive and share based compensation plans changed year-over-year?
West Pharmaceutical Services's proceeds from issuance of shares under incentive and share based compensation plans increased by 5.3% year-over-year, from $1.90M to $2.00M.
What is the long-term trend for West Pharmaceutical Services's proceeds from issuance of shares under incentive and share based compensation plans?
Over 3 years (2021 to 2025), West Pharmaceutical Services's proceeds from issuance of shares under incentive and share based compensation plans has grown at a -3.6% compound annual growth rate (CAGR), from $7.70M to $6.90M.